basis to over and first last consolidated with organic billion, adjusted of quarter Thanks, for revenues My refer thanks organic Tom. Bosch Hello, comments the $X.X the results. joining us. quarter X% today for closed everyone, Health quarter and growth same on will up year. We an
First organic our quarter $X for billion and Solta Bosch excluding on Health flat Salix, B+L growth International in were revenues with businesses. an basis, and
segment shown each in as discuss XX. me Slide on detail Let greater
inventory the our X%. In clinics, the changes market we as in to quarter, prior revenue coupled Salix TRULANCE channel see increasing higher X% XXX million. overall the XIFAXAN this to inventory revenues the increase favorable demand quarter grew outpatient due in such in X% grew First $XXX uptick for and was comparison demand XXX, at continued increased channel This XIFAXAN with first in changes and institutions, non-retail quarter, quarter in to relatively TRULANCE an with share. and RELISTOR, for year. and largely hospitals XIFAXAN demand
shift care post-COVID we facilities, this trend. the long-term on We going than a patient are also saw long-term hospital directly step-down ongoing, we but increase from rather a the from patients the home journey facilities keeping care eye close believe slight a to demand or with in and in HE
increased investments the Salix invest plan we As and in remainder our have of said, quarter the Tom further XXXX. we during in to
were revenues strong Poland during first and Canada growth International XX%, X% also of the We XX% XX% by of which the million, of with and an organic growth script an year. in XX% the prior $XXX quarter first led TRULANCE, versus performance respectively increases on of basis and quarter, RELISTOR the driven respectively. by posted increase of are in and XX% total and pleased sales XX%
in saw key of growth We double-digit also a brands. number
Solta Medical organic revenues on an in $XX the X% basis first of quarter. million increased
a the part the despite opening market quarter, effects Our up China from Asia due to demand of the of restrictions COVID-related government the decline Pacific strong in in COVID. business grew X% immediately first early with following the of sales
down slightly Excluding the China, volumes. In driven grew were region the lower sales XX%. U.S. by
in We are expansion Europe. teams the campaign DTC continuing the U.S. and the of of in expansion our sales
first revenues Diversified basis down XX% an were million, on organic in $XXX the quarter.
at pricing net part by patient lower were neurology, coverage in well on script pressure growth the QX, quarter. X%. of of the effect product as For offset in In WELLBUTRIN, JUBLIA were mix, beginning positive mainly were demand pricing, decreases XX%. dermatology, sales Dentistry scripts impacted net of patient driven by a is sales our growth partially in higher for reset sales reduced remained as APLENZIN, JUBLIA the deductibles lower as These ARESTIN, shift had APLENZIN although X% which grew year. at in the which which by
in to dermatology generic market continue conditions the our on the this year, focused for the expect challenging portfolio. and neurology, We businesses balance part remained and of stabilizing of
revenues Lastly X% across quarter, on on strong organic basis + Slide with B+L up were $XXX in growth an Lomb the million, XX, Bausch segments. all organic first
performance and the also quarter of on Health XX, some I'll P&L to excluding on first color basis B+L. a Bosch additional results refer Slide to for consolidated provide Turning the the for
consolidated margin gross was in XXX At excluding B+L, points pricing was quarter XX.X%, prior XX the approximately Health, driven with decrease was points XX.X%, year. adjustments the gross quarter for year. the than mainly The the by adjusted last basis year. net The first favorable prior basis compared Bausch adjusted first lower margin lower
of in higher On an expenses million higher by was of SG&A pockets the unfavorable $XXX driven gross mainly million, supply the increase quarter costs and of first mix or product operating side, the were expenses. with B+L adjusted inventory, XX% for challenges. R&D change $XXX Consolidated margin and
sales and of and increase the advertising and marketing in B+L impact increased $XX up companies. Salix Bosch increase operating Health $XX to go-to-market to the Health in we activity. promotional in two adjusted the G&A costs making investments Selling expenses due and Bosch force, the are approximately reported reflects channels increased for excluding public The stand consolidated For the expenses. separation an B+L million operating increased B+L, costs million by while excluding of
in major Bosch XXXX. consolidated we The We're reducing increased prior platform, year rest the B+L to of dedicated the net a and B+L from our reliance increased we operations our transition services. to Health IT represented from for are driven of settlement on received favorable Ireland Enterprise sales, the of by with or flat infrastructure progress TSA on million excluding the G&A and Adjusted of migrated ERP a make separating QX continue the by note, and $XX meaning fees relating business, Also a dispute compared that contractual in of the to Planning impact pharma significant and U.S. in new of in XX% all B+L's company markets our received first expense successfully X% systems. quarter Resource year. R&D last process
R&D our our Salix, by development. million, clinical activities to Bosch and for For increased programs stage primarily late B+L, on and due support Health excluding to $XX approximately the mid focus regulatory expenses product
last First the includes XX% attributable quarter decrease year. of consolidated $XXX a adjusted interest. This was which of to EBITDA versus adjusted EBITDA million, B+L was $XX million minority
B+L, On excluding XX.X%, XX% consolidated was reflecting last quarter margin Adjusted XX.X% year, a adjusted margin decrease XX% the + Bosch was compared described. last from for the factors adjusted Health EBITDA of EBITDA first XX%. for B+L a previously with was For EBITDA and Lomb Health Bosch was Bosch basis, excluding $XXX million, year.
our impacted me year debt in accounting on interest quarter. The the the this lowering it exchange last we the million expense, for GAAP significantly expense Let quarter. $XX GAAP required by reporting briefly are touch interest
be based on excluding debt approximately $XXX interest substantial which interest payments and As on on million a for the reduced interest you balances are principal consolidated was been premium, the for the made. may portion B+L. as basis newly Contractual a recall, costs $XXX quarter million balance the sheet as a Bosch on of has Health recorded issued will
versus to flow flow, year. Turning on first in million quarter $XXX was cash cash adjusted operations million the consolidated basis last from a $XX
adjustments For contractual of transformation costs, cash of costs, flow Bosch full was and includes payment cash million from Adjusted in interest. the the flow the operations adjusted Health also expectations. $XX business our excluding includes B+L, was payments with line which for separation
working as affected flow as payments. payments timing movements, This due unfavorable coupon lumpiness cash higher of certain well quarter's the the to of interest capital by was interest
on Now sheet our turn to Slide let's balance XX.
balance excluding the we of of our Bosch by As is delevering $XXX million process ongoing. reduced for Tom the XXXX, have quarter B+L mentioned our repayments. revolver debt And first sheet earlier, in Health including
restricted billion subsidiary of unrestricted of XX slides end As Bosch year. of Health the $XX.X in secured which Lomb billion debt by debt Bosch and B+L, XX third for issued notes show, and $X was quarter total quarter billion of issued + $XX.X Bosch by the excluding the created last Health senior excluding the of at consisted
approximately the is a consolidated debt our is company's debt, basis debt fixed. of of B+L XX% XX% fixed. Excluding Approximately on
XXXX Slide viewed on Bosch Our guidance for unchanged, B+L is can be XX. and excluding Health
we in $X.XX $X.X For billion basis. organic B+L on excluding for X% billion continue year of Bosch Health to an is representing adjusted excluding revenues X% to expect still B+L, billion. expected Bosch the range $X.X EBITDA growth Health billion Full $X.X be to of to to
reminder, a increased year. versus investments reflect our As expectations EBITDA last
we continue segments. invest DTC Canada. expanding our in the our key sales institutional and to investments launch in RELISTOR and Medical our exciting and to footprint, for first in marketing Salix, HE brands force growth sales marketing We Salix and activities products include campaign in These International Solta like campaigns drive as UCERIS
of in this expect see later XXXX benefit We XXXX. into and to spending the
the line expectations through R&D expectations. product our with maintain the quarter first are of pipeline the our year. performance progress in progress As our to Tom making and in we Health The this mentioned for EBITDA with rest increased also excluding pleased the spending earlier, we on are B+L was Bosch reflect
subsequent of cost. resetting annual is first the our call out-of-pocket the quarters, due in to the year which weaker than quarter, health quarter of States, typically mentioned deductibles patient the I United impacts insurance in the three As the last
in are through While provide four, sales guidance when to relative also to will our marketing start investments the the benefits anticipate quarter, for growth expectations we two our materialize. we don't from and stronger quarters by quarter, first
full non-GAAP below tax be expected EBITDA, year effective our Moving rate is to XX%. approximately
contractual to $X.X We expect unchanged billion. remain at approximately interest our cost
$XXX to adjusted excluding flow. Bosch operating Health continue million approximately to B+L we cash generate Lastly, expect in
a tax As estimated for costs, adjusted of cash payment adjustments also contractual Trust I inclusive of Granite payments flow of the separation settlement. includes and cash earlier, the the full said interest payment includes tentative
I'll back now call the to Tom. hand
